Cargando…

Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials

CONTEXT: Participants with stage 1 or 2 type 1 diabetes (T1D) qualify for prevention trials, but factors involved in screening for such trials are largely unknown. OBJECTIVE: To identify factors associated with screening for T1D prevention trials. METHODS: This study included TrialNet Pathway to Pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinney, Mara, You, Lu, Sims, Emily K, Wherrett, Diane, Schatz, Desmond, Lord, Sandra, Krischer, Jeffrey, Russell, William E, Gottlieb, Peter A, Libman, Ingrid, Buckner, Jane, DiMeglio, Linda A, Herold, Kevan C, Steck, Andrea K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891344/ https://www.ncbi.nlm.nih.gov/pubmed/36741943 http://dx.doi.org/10.1210/jendso/bvad003

Ejemplares similares

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood
por: Vehik, Kendra, et al.
Publicado: (2011)

Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report
por: Wherrett, Diane K., et al.
Publicado: (2015)

Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention. Diabetes Care 2019;42:2228–2236
por: Sims, Emily K., et al.
Publicado: (2020)

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
por: Orban, Tihamer, et al.
Publicado: (2014)

Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
por: Russell, William E., et al.
Publicado: (2023)

The Evolution of Hemoglobin A(1c) Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
por: Redondo, Maria J., et al.
Publicado: (2021)

Prediction of congenital hypothyroidism based on initial screening thyroid-stimulating-hormone
por: Saleh, David S., et al.
Publicado: (2016)

A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History
por: Sosenko, Jay M., et al.
Publicado: (2015)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA(1c), and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
por: Haller, Michael J., et al.
Publicado: (2019)

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
por: Anderson, Randy L., et al.
Publicado: (2022)

Improving Prediction of Risk for the Development of Type 1 Diabetes—Insights From Populations at High Risk
por: Wherrett, Diane K.
Publicado: (2021)

Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample
por: Bediaga, Naiara G., et al.
Publicado: (2021)

Use of an electronic medical record reminder improves HIV screening
por: Kershaw, Colleen, et al.
Publicado: (2018)

Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes
por: Simmons, Kimber M., et al.
Publicado: (2019)

Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines
por: Wood, Jamie R., et al.
Publicado: (2013)

Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2020)

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
por: Insel, Richard A., et al.
Publicado: (2015)

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2021)

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes
por: Xu, Ping, et al.
Publicado: (2014)

Content analysis of locum tenens recruitment emails for anesthesiologists
por: DiMeglio, Matthew, et al.
Publicado: (2018)

Self-Assessment of Preparedness among Critical Care Trainees Transitioning from Fellowship to Practice
por: Watkins, Laura, et al.
Publicado: (2019)

The Impact of an International Elective on Anesthesiology Residents as Assessed by a Longitudinal Study
por: Dohlman, Lena, et al.
Publicado: (2019)

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial
por: Vehik, Kendra, et al.
Publicado: (2011)

Natural mucosal barriers and COVID-19 in children
por: Pierce, Carl A., et al.
Publicado: (2021)

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2021)

Barriers to delirium screening and management during hospital admission: a qualitative analysis of inpatient nursing perspectives
por: Ragheb, Jacqueline, et al.
Publicado: (2023)

Screening of Cervical Cancer: Barriers and Facilitators
por: Shrivastava, Saurabh R, et al.
Publicado: (2013)

Barriers to Colorectal Cancer Screening in Pakistan
por: Hasan, Fariha, et al.
Publicado: (2017)

Efficient Reduction of CO(2) to CO with High Current Density Using in Situ or ex Situ Prepared Bi-Based Materials
por: Medina-Ramos, Jonnathan, et al.
Publicado: (2014)

Behavioural patterns of electrolyte repletion in intensive care units: lessons from a large electronic dataset
por: Joseph, Thomas T., et al.
Publicado: (2018)

Global Brain Drain: How Can the Maslow Theory of Motivation Improve Our Understanding of Physician Migration?
por: Dohlman, Lena, et al.
Publicado: (2019)

4033 Evaluating the Effect of Prebiotics on the Gut Microbiome Profile and Beta-cell Function in Newly-Diagnosed Type 1 Diabetes
por: Ismail, Heba M, et al.
Publicado: (2020)

LBSUN309 The Effect Of Prebiotics In Newly Diagnosed Youth With Type 1 Diabetes (T1D)
por: Ismail, Heba, et al.
Publicado: (2022)

Rituximab Selectively Suppresses Specific Islet Antibodies
por: Yu, Liping, et al.
Publicado: (2011)

Screening for Park Access during a Primary Care Social Determinants Screen
por: Razani, Nooshin, et al.
Publicado: (2020)

RNA interference screening demystified
por: Lord, C J, et al.
Publicado: (2009)

Colorectal Cancer Screening in Ghana: Physicians’ Practices and Perceived Barriers
por: Lussiez, Alisha, et al.
Publicado: (2020)

Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review
por: Kirubarajan, Abirami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kn9f83bnbgt0ufupuebg1k2nvp